Literature DB >> 12381705

Preferential DNA damage and poor repair determine ras gene mutational hotspot in human cancer.

Zhaohui Feng1, Wenwei Hu, James X Chen, Annie Pao, Haiying Li, William Rom, Mien-Chie Hung, Moon-shong Tang.   

Abstract

BACKGROUND: Mutations in ras genes are commonly found in human cancers and in animal models. Although mutations at codons 12, 13, and 61 of H-, N- and K-ras genes can activate their oncogenic function, mutations at codon 12 of K-ras are the most common mutations found among the three ras genes in human cancers. To investigate whether codon 12 of human K-ras is especially susceptible to carcinogens and/or whether carcinogen-DNA adducts at this codon are repaired less efficiently, we examined tobacco smoke carcinogen-induced DNA damage in normal human bronchial epithelial and fibroblast cells.
METHODS: We used the UvrABC nuclease incision method in combination with ligation-mediated polymerase chain reaction to map the distribution of DNA adducts induced by benzo[a]pyrene diol epoxide (BPDE) and other bulky carcinogens within exons 1 and 2 in H-ras, N-ras, and K-ras. We also analyzed BPDE-DNA adduct repair efficiency in these three genes using the same method.
RESULTS: Codons 12 and 14 of the K-ras gene were hotspots for carcinogen-DNA adduct formation, with little and no adduct formation at codons 13 and 61, respectively. The BPDE-DNA adducts formed at codon 14 were repaired almost twice as quickly as those formed at codon 12. There was some BPDE-DNA adduct formation at codons 12 of H-ras and N-ras, but this codon was not a hotspot. Furthermore, no substantial difference in repair rates between codon 12 and the other codons analyzed (codons 3 and 18) was observed in either the H-ras or N-ras genes.
CONCLUSION: These findings link the human cancer mutational hotspot at codon 12 of K-ras to preferential DNA damage and poor repair.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12381705     DOI: 10.1093/jnci/94.20.1527

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  27 in total

1.  Sequence-dependent structural variation in DNA undergoing intrahelical inspection by the DNA glycosylase MutM.

Authors:  Rou-Jia Sung; Michael Zhang; Yan Qi; Gregory L Verdine
Journal:  J Biol Chem       Date:  2012-03-30       Impact factor: 5.157

2.  Analysis of acrolein-derived 1,N2-propanodeoxyguanosine adducts in human leukocyte DNA from smokers and nonsmokers.

Authors:  Siyi Zhang; Silvia Balbo; Mingyao Wang; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2010-11-22       Impact factor: 3.739

Review 3.  Molecular processes that drive cigarette smoke-induced epithelial cell fate of the lung.

Authors:  Toru Nyunoya; Yohannes Mebratu; Amelia Contreras; Monica Delgado; Hitendra S Chand; Yohannes Tesfaigzi
Journal:  Am J Respir Cell Mol Biol       Date:  2014-03       Impact factor: 6.914

Review 4.  Genetic status of KRAS influences Transforming Growth Factor-beta (TGF-β) signaling: An insight into Neuropilin-1 (NRP1) mediated tumorigenesis.

Authors:  Sneha Vivekanandhan; Debabrata Mukhopadhyay
Journal:  Semin Cancer Biol       Date:  2018-02-02       Impact factor: 15.707

Review 5.  Second-hand smoke and human lung cancer.

Authors:  Ahmad Besaratinia; Gerd P Pfeifer
Journal:  Lancet Oncol       Date:  2008-07       Impact factor: 41.316

6.  Absence of Ras, c-myc and Epidermal Growth Factor Receptor (EGFR) Mutations in Human Gliomas and its Clinical Factors Associated with Pathological Grading After Six Years of Diagnosis in North East Malaysian Patients.

Authors:  Mazira Mohammad Ghazali; Mohd Shahril Mohd Zan; Abdul Aziz Yusof; Jafri Malin Abdullah; Hasnan Jaffar; Abdul Rahman Ariff; Win Mar Slamah; Aini Ideris; Abdul Manaf Ali; Abdul Rahman Omar; Khatijah Yuosff; Mohd Azmi Mohd Lila; Fauziah Othman; Noordin Mohamed Mustapha; Mohd Nizam Isa; Nyi Nyi Naing
Journal:  Malays J Med Sci       Date:  2005-07

7.  Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair.

Authors:  Zhaohui Feng; Wenwei Hu; Yu Hu; Moon-shong Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-09       Impact factor: 11.205

8.  Expression and mutation analysis of heterogeneous nuclear ribonucleoprotein G in human oral cancer.

Authors:  Ki-Hyuk Shin; Reuben H Kim; Bo Yu; Mo K Kang; David Elashoff; Russell Christensen; Ana Pucar; No-Hee Park
Journal:  Oral Oncol       Date:  2011-08-12       Impact factor: 5.337

9.  Regulation of therapeutic resistance in cancers by receptor tyrosine kinases.

Authors:  Mei-Kuang Chen; Mien-Chie Hung
Journal:  Am J Cancer Res       Date:  2016-03-15       Impact factor: 6.166

10.  Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy.

Authors:  Frances A Shepherd; Caroline Domerg; Pierre Hainaut; Pasi A Jänne; Jean-Pierre Pignon; Stephen Graziano; Jean-Yves Douillard; Elizabeth Brambilla; Thierry Le Chevalier; Lesley Seymour; Abderrahmane Bourredjem; Gwénaël Le Teuff; Robert Pirker; Martin Filipits; Rafael Rosell; Robert Kratzke; Bizhan Bandarchi; Xiaoli Ma; Marzia Capelletti; Jean-Charles Soria; Ming-Sound Tsao
Journal:  J Clin Oncol       Date:  2013-04-29       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.